UROCIT-K 540 MG — DIN 01914022
POTASSIUM CITRATE : 540 MG · MISSION PHARMACAL COMPANY · TABLET (EXTENDED-RELEASE) · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is UROCIT-K?
UROCIT-K 540 MG contains POTASSIUM CITRATE : 540 MG. It is listed in the Health Canada Drug Product Database under DIN 01914022, held by MISSION PHARMACAL COMPANY, supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 17-Sep-2024. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Potassium Citrate in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
6 holders have a Canadian DIN containing Potassium Citrate, across 7 DINs, of which 1 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| MISSION PHARMACAL COMPANY | 2 | 1 | UROCIT-K | Sourceable in Canada |
| ALZA CORPORATION | 1 | 0 | POLYCITRA-K | No marketed DIN |
| BIOFORCE CANADA INC. | 1 | 0 | POTASSIUM 99MG TABLETS | No marketed DIN |
| BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | 1 | 0 | K LYTE TAB LIME & ORANGE FLAV | No marketed DIN |
| DA VINCI LABORATORIES, DIVISION OF FOODSCIENCE CORPORATION | 1 | 0 | POTASSIUM TAB 99MG | No marketed DIN |
| JANSSEN INC | 1 | 0 | POLYCITRA-K | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 540 MG |
|---|---|
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Potassium Citrate |
|---|---|
| ATC code | A12BA02 |
| AHFS class | 12:12.08.08 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01914022 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1914022 |
| Brand name | UROCIT-K |
| Generic / active ingredient | POTASSIUM CITRATE : 540 MG |
| Market authorization holder | MISSION PHARMACAL COMPANY |
| Health Canada schedule | Prescription |
| ATC code | A12BA02 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A12BA |
| Current status | CANCELLED POST MARKET |
| Status date | 17-Sep-2024 |
| Original market date | 1993-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Potassium Citrate in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
1 of 7 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| UROCIT-K | 1080 MG | TABLET (EXTENDED-RELEASE) | MISSION PHARMACAL COMPANY | MARKETED | 02353997 |
| K LYTE TAB LIME & ORANGE FLAV | 975 MG | TABLET (EFFERVESCENT) | BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | CANCELLED POST MARKET | 00477117 |
| POLYCITRA-K | 398 MG / 5 ML | SOLUTION | JANSSEN INC | CANCELLED POST MARKET | 02163233 |
| POLYCITRA-K | 1.193 G / 4.5 G | POWDER | ALZA CORPORATION | CANCELLED POST MARKET | 02163241 |
| POTASSIUM 99MG TABLETS | 99 MG | TABLET | BIOFORCE CANADA INC. | CANCELLED POST MARKET | 02075962 |
| POTASSIUM TAB 99MG | 99 MG | TABLET | DA VINCI LABORATORIES, DIVISION OF FOODSCIENCE CORPORATION | CANCELLED POST MARKET | 00519480 |
2 · Same class — other molecules in ATC A12BA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Potassium Chloride | HI POTENCY POTASSIUM CHLORIDE · K C1-ROUGIER · K LOR GRANULES 20MEQ · K LYTE CL PWR · +17 more | 21 | 1 | Yes |
| Potassium Citrate | K LYTE TAB LIME & ORANGE FLAV · POLYCITRA-K · POTASSIUM 99MG TABLETS · POTASSIUM TAB 99MG · +1 more | 7 | 1 | Yes |
| Potassium Gluconate | KAON · POTASSIUM 99 - CAPLET · POTASSIUM GLUCONATE TAB 550MG USP · POTASSIUM GLUCONATE TABLETS 99MG USP · +3 more | 7 | 0 | Not in Canada |
| Potassium (Different Salts In Combination) | IODE-POTASSIUM · NEO K · POTASSIUM-NOVARTIS | 3 | 0 | Not in Canada |
| Potassium Chloride, Combinations | K-MED · POTASSIUM AND IODINE TAB | 3 | 0 | Not in Canada |
| Potassium | POTASSIUM 250 | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is UROCIT-K called?
Also recorded in Canada as: citric acid 1002 MG / potassium citrate 3300 MG Powder for Oral Solution [Cytra-K] (US), citric acid 66.8 MG/ML / potassium citrate 220 MG/ML Oral Solution [Cytra-K] (US), potassium citrate 10 MEQ Extended Release Oral Tablet [Urocit-K] (US), potassium citrate 5 MEQ Extended Release Oral Tablet [Urocit-K] (US), citric acid 66.8 MG/ML / potassium citrate 110 MG/ML / sodium citrate 100 MG/ML Oral Solution [Cytra-3] (US), potassium citrate 15 MEQ Extended Release Oral Tablet [Urocit-K] (US), citric acid 1002 MG / potassium citrate 3300 MG Powder for Oral Solution (US), potassium citrate 5 MEQ Extended Release Oral Tablet (US), potassium citrate 10 MEQ Extended Release Oral Tablet (US), potassium citrate 99 MG Oral Capsule (US), citric acid 66.8 MG/ML / potassium citrate 110 MG/ML / sodium citrate 100 MG/ML Oral Solution (US), citric acid 66.8 MG/ML / potassium citrate 220 MG/ML Oral Solution (US), magnesium citrate 70 MG / potassium citrate 99 MG Oral Capsule (US), potassium citrate 15 MEQ Extended Release Oral Tablet (US), POTASSIUM CITRATE (US).
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.